Comparison of Gd-DTPA and Gd-BOPTA for studying renal perfusion and filtration
✍ Scribed by Mike Notohamiprodjo; Michael Pedersen; Christian Glaser; Andreas D. Helck; Klaus-Peter Lodemann; Bente Jespersen; Michael Fischereder; Maximilian F. Reiser; Steven P. Sourbron
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 480 KB
- Volume
- 34
- Category
- Article
- ISSN
- 1053-1807
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Purpose:
To measure the systematic error in perfusion and filtration parameters derived from magnetic resonance (MR) renography caused by protein binding of MR contrast agents.
Materials and Methods:
Eight healthy Danish Landrace pigs were examined with dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI). In four pigs a bolus of gadopentetate‐dimeglumine (Gd‐DTPA; no protein binding) was injected, followed by gadobenate‐dimeglumine (Gd‐BOPTA; 10% protein binding). The order was reversed in the other four pigs. A two‐compartment filtration model was generalized to allow for protein binding and fitted to whole‐cortex region of interest (ROI) curves. Single‐kidney plasma flow and volume, tubular flow (or GFR), and tubular transit time of both agents were compared.
Results:
The data show a strong systematic underestimation (P < 0.001) in GFR by Gd‐BOPTA (33 ± 7.2%), and no significant differences (P > 0.05) in plasma flow (2.2 ± 18%), plasma volume (−1.7 ± 7.8%) and tubular transit time (3.1 ± 7.2%). The order of injection had no significant effect.
Conclusion:
Theory and experiments agree that perfusion parameters of both agents are comparable, whereas GFR is underestimated with Gd‐BOPTA due to the dependence of relaxivity on protein content. Hence, GFR cannot be measured with protein‐bound contrast agents, but the proposed dual‐agent protocol may produce new functional indices measuring protein filtration. J. Magn. Reson. Imaging 2011;. © 2011 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract A new hepatobiliary contrast agent for magnetic resonance (MR) imaging, gadolinium‐ethoxybenzy1 (EOB)‐diethylemetriaminepentaacetic acid (DTPA), was compared with Gd‐DTPA to define the potential for improving tumor‐liver contrast in a rodent liver adenocarcinoma model. With a T1‐weighte
## Purpose: To investigate the characteristics of gd-dtpa-dea as a hepatobiliary contrast agent for mr imaging in comparison with those of gd-eob-dtpa. ## Materials and methods: We undertook phantom experiments to assess t1 relaxivity for gd-dtpa-dea, gd-eob-dtpa, and gd-dtpa in human plasma. for